Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Trump’s Election Could Bring ‘Best Of Times’ For Pharma

Executive Summary

Obama administration wasn’t bad but had ‘less than thrilling moments,’ BIO exec says; former FDA Commissioner says leadership, not scientific, skill is key attribute for next agency chief.


Related Content

Trump Win Is False Security For Drug Makers, Allergan CEO Warns
Who To Watch In Health Care Policy Under Trump
Trump’s FDA Reform Agenda: Patient-Focused Approvals
The Trump Rally: GOP Sweep Is Good News For Biopharma – But Don’t Get Carried Away
Pharma Is Ready And Waiting For A Tax Holiday Under Trump
Califf's Priorities Feature Short- And Long-Term Goals Despite Potentially Brief Tenure
Biden’s Cancer Initiative May Intensify Industry, Government Collaboration
The Campaign Against Drug Pricing: Candidates Can Only Hope Voters React As Strongly As Wall Street


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts